Latest News of AQST
Investors in Aquestive Therapeutics (NASDAQ:AQST) have unfortunately lost 36% over the last five years
By Yahoo! Finance |
5 months ago
Aquestive Therapeutics' stock has declined significantly in the past five years due to shrinking revenue. Shareholders hope for strong revenue growth to offset lack of profits. Recent improvement in t...